Cellular immunity in recurrent vulvovaginal candidiasis

Clinical and Experimental Immunology

Volumn 111, Issue 3, 1998, Pages 574-578

  Corrigan, E M ^a,b   Clancy, R L ^a   Dunkley, M L ^a   Eyers, F M ^a   Beagley, K W ^a  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b Australian Inst of Mucosal Immunol   (Australia)

Author keywords

Candida albicans; Cell mediated immunity; DTH menstrual cycle; Interferon gamma

Indexed keywords

GAMMA INTERFERON;

ADULT; ARTICLE; CELL PROLIFERATION; CELLULAR IMMUNITY; CLINICAL ARTICLE; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FEMALE; FOLLICULAR PHASE; HORMONE RESPONSE; HOST RESISTANCE; HUMAN; LUTEAL PHASE; MENSTRUAL CYCLE; PRIORITY JOURNAL; RECURRENT DISEASE; RISK FACTOR; VAGINA CANDIDIASIS;

ADULT; ANTIGENS, FUNGAL; CANDIDA; CANDIDIASIS, VULVOVAGINAL; CYTOKINES; FEMALE; FOLLICULAR PHASE; HUMANS; HYPERSENSITIVITY, DELAYED; IMMUNITY, CELLULAR; LUTEAL PHASE; LYMPHOCYTE ACTIVATION; MIDDLE AGED; PHYTOHEMAGGLUTININS; T-LYMPHOCYTES;

EID: 0031921365     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1998.00525.x     Document Type: Article

References (30)

1. Hurley R. Recurrent Candida infection. Clin Obstet Gynecol 1981; 8:209-13.
2. Klein RS, Harris CA, Small CB et al. Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome. N Engl J Med 1984; 311:354-8.
3. Clift RA. Candidiasis in the transplant patient. Am J Med 1984; 77 (Suppl. 4D):34-38.
4. Syverson RE, Buckley H, Gibian J, Ryan GM. Cellular and humoral immune status in women with chronic Candida vaginitis. Am J Obstet Gynecol 1979; 134:624-7.
5. Fong IW, McCleary P, Read S. Cellular immunity of patients with recurrent or refractory vulvovaginal moniliasis. Am J Obstet Gynecol 1992; 166:887-90.
6. Fidel PL Jr, Lynch ME, Redondo-Lopez V et al. Systemic cell-mediated immune reactivity in women with recurrent vulvovaginal candidiasis. J Infect Dis 1993; 168:1458-65.
7. Hobbs JR, Briden D, Davidson F et al. Immunological aspects of candidal vaginitis. Proc R Soc Med 1977; 70:11-14.
8. Witkin SS, Yu IR, Ledger WJ. Inhibition of Candida albicans-Induced lymphocyte proliferation by lymphocytes and sera from women with recurrent vaginitis. Am J Obstet Gynecol 1983; 147:809-11.
9. Witkin SS, Hirsch J, Ledger WJ. A macrophage detect in women with recurrent Candida vaginitis and its reversal in vitro by prostaglandin inhibitors. Am J Ohstet Oynecol 1986; 155:790-5.
10. Mathur S, Mathur RS, Dowda H et al. Sex steroid hormones and antibodies to Candida albicans. Clin Exp Immunol 1978; 33:79-87.
11. Wira CR, Stern JE. Endocrire regulation of the mucosal immune system in the female reproductive tract. Control of IgA, IgG and secretory component during the reproductive cycle, at implantation and throughout pregnancy. In: Fasqualini JR, Scholler R, eds. Hormones and fetal pathophysiology. New York: M. Dekker, 1992:343-67.
12. Wira CR, Sandoe CP. Sex stero d hormone regulation of IgA and IgG in rat uterine secretions. Nature 1977; 268:534-6.
13. Wira CR, Sullivan DA. Estradiol and progesterone regulation of immunoglobulin A and G and secretory component in cervicovaginal secretions of the rat. Biol Reprod 1985; 32:90-95.
14. Wira CR, Rossoll RM. Antigen-presenting cells in the female reproductive tract: influence of sex hormones on antigen presentation in the vagina. Immunology 1995; 84:505-8.
15. Wira CR, White H, Yeaman GR. Endocrine regulation of mucosal immunity in the human female reproductive tract. Immunol Cell Biol 1997; 75 (Suppl. 1):A10 (Abstr.).
16. Modlin RL. Th1-Th2 paradigm: insights from leprosy. J Invest Dermatol 1994; 102:828-32.
17. Kent HL. Epidemiology of vaginitis. Am J Obstet Gynecol 1991; 165:1168-76.
18. McDermott MR, Clark DA, Bienenstock J. Evidence for a common mucosal immunologic system II. Influence of the estrous cycle on B lymphoblast migration into genital and intestinal tissues. J Immunol 1980; 124:2536-9.
19. Kalo-Klein A, Witkin SS. Candida albicans: cellular immune system interactions during different stages of the menstrual cycle. Am J Obstet Gynecol 1989; 161:1132-6.
20. Sobel JD. Candidal vulvovaginit s. Clin Obstet Gynecol 1993; 36:153-65.
21. Odds FC. Factors that predispose the host to candidosis. In: Odds FC, ed. Candida and candidosis. Baltimore: University Park Press, 1979:74-91.
22. Sobel JD, Muller G, McCormick JF. Experimental chronic vaginal candidosis in rats. Sabouraudia 1985; 23:199-206.
23. 1 mice. Immunology 1991; 73:186-90.
24. Styrt B, Sugarman B. Estrogens and infection. Rev Infect Dis 1991; 13:1139-50.
25. Fox HS, Bond BL, Parslow TG Estrogen regulates the IFN-γ promoter. J Immunol 1991; 146:4362-7.
26. Kalo-Klein A, Witkin SS. Regulation of the immune response to Candida albicans by monocytes and progesterone. Am J Obstet Gynecol 1991; 164:1351-4.
27. Skowronski R, Feldman D. Characterization of an estrogen-binding protein in the yeast Candida albicans. Endocrinology 1989; 124:1965-72.
28. Kinsman OS, Pitblado K, Coulson CJ. Effect of mammalian steroid hormones and luteinizing hormone on the germination of Candida albicans and implications for vaginal candidosis. Mycoses 1988; 31:617-26.
29. Loose DS, Schurman DJ, Feldman D. A corticosteroid binding protein and endogenous ligand in C. albicans indicating a possible steroid-receptor system. Nature 1981; 293:477-9.
30. Loose DS, Feldman D. Characterization of a unique corticosterone binding protein in Candida albicans. J Biol Chem 1982; 257:4925-30.